newstock.ai
← Back

DHRDanaher

$200.14-0.19%Real quote · delayedLife sciencesMedtech & life sciences · 10 peers →

🏛️ Company factsSEC filings + FINRA official data

Annual revenue $24.6B · latest quarter up 5.5% YoY · profitable (FY net income $3.6B) · short activity below its recent average — bears covering.

FY revenue

$24.6B

2025-12

Latest Q YoY

+5.5%

Gross margin

59.1%

FY net income

$3.6B

Diluted EPS

$5.07

Short volume

27.9%

20d avg 39.8% · shorts covering

🐋 5%+ ownership filings (last 180d)

The parties below hold over 5% of this company and disclosed it to the SEC (mandatory in US markets). "Activist" filers state an intent to influence the company; "Passive" are pure investment positions.

🎯 Market expectations

Expectation reliability High · 79/100

Nasdaq analyst consensus · the pre-news baseline

Next quarter (Sep 2026) consensus$1.96Estimate range $1.91 ~ $2.10 · 9 analysts
History: actual vs consensusavg +5.7%
  • Jun 2026$1.94 vs $1.84+5.43%
  • Mar 2026$2.06 vs $1.94+6.19%
  • Dec 2025$2.23 vs $2.22+0.45%
  • Sep 2025$1.89 vs $1.71+10.53%

The takeaway

This company habitually beats by +5.7% — the next report has to clear that bar to count as good news.

Analyst estimates, not our forecast · not investment advice

What's moving this stock lately

No recent news affecting this stock

🕰️ Price × news · engine report card

Drag to pan, scroll to zoom · real daily bars and volume

volume
🔒 Pro only

Impact chains · crowding · conviction engine · insider signals — free 7-day trial on signup.

Sign up · free 7-day trial →